 Home > Medical News > Latest Medical News > Hanguang Pharmaceutical Nitisinone Approved to Treat Type 1 Tyrosinemia Patients

Hanguang Pharmaceutical Nitisinone Approved to Treat Type 1 Tyrosinemia Patients

 Last Update: 2021-08-30
 Source: Internet
 Author: User

Tags

adulterants drug test

drug compatibility chart

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 21, the drug approval document issued by the National Food and Drug Administration (NMPA) of China showed that Nitisinong capsules declared by Hanguang Pharmaceutical have been approved for marketing in China

Screenshot source: NMPA official website

Public information shows that nitisinone is the first choice for the treatment of type 1 tyrosinemia (HT-1) internationally, and the original nitisinone drug has not been approved in China

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.